Concepedia
Publication | Closed Access
Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1′-Hydroxylation
51
Citations
25
References
2011
Year
Page 1